Sol-gel technologies to participate in upcoming lifesci partners corporate access event and h.c. wainwright bioconnect 2022 healthcare conference

Ness ziona, israel, dec. 22, 2021 (globe newswire) -- sol-gel technologies, ltd. (nasdaq: slgl), a clinical-stage dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases, today announced that the company will participate in the lifesci partners 11th annual corporate access event and the h.c. wainwright bioconnect conference, both of which will be held virtually.
SLGL Ratings Summary
SLGL Quant Ranking